Modified responsiveness of v-Ha-ras-transfected rat fibroblasts to growth factors and a tumor promoter
- PMID: 3076452
- DOI: 10.1002/mc.2940010206
Modified responsiveness of v-Ha-ras-transfected rat fibroblasts to growth factors and a tumor promoter
Abstract
The correlation of the phenotypic changes of v-Ha-ras transfected cells with the expression of p21ras and the modified responses to growth factors and a tumor promoter were examined. Transfection of the v-Ha-ras gene together with the neomycin-resistance gene into 208F rat fibroblasts yielded transformed clones characterized by morphological changes, anchorage-independent growth, and tumorigenicity in nude mice. The degrees of these biological alterations were parallel with the expression of mRNA and protein of the ras gene. In ras-transformed cells, anchorage-independent growth was stimulated by epidermal growth factor (EGF), insulin, bombesin, and fibroblast growth factor, whereas in the parental 208F cells, anchorage-independent growth was observed only in the presence of EGF, and there were many fewer EGF-induced colonies than those in the ras-transformed clones. A tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) also augmented anchorage-independent growth of ras-transformed cells and induced morphological changes in monolayer cultures without altering the expression of the ras gene or phosphorylation of the p21ras protein. Retinoic acid inhibited the TPA-induced anchorage-independent growth. These results showed a good correlation of the expression of p21ras with the phenotypic changes and the increased sensitivity of the p21ras-expressing cells to the stimulation of growth factors and tumor promoter.
Similar articles
-
Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.Cell Growth Differ. 1990 Sep;1(9):407-20. Cell Growth Differ. 1990. PMID: 1981145
-
Differential response to retinoic acid of Syrian hamster embryo fibroblasts expressing v-src or v-Ha-ras oncogenes.Mol Cell Biol. 1986 Oct;6(10):3341-8. doi: 10.1128/mcb.6.10.3341-3348.1986. Mol Cell Biol. 1986. PMID: 3025589 Free PMC article.
-
Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.Cancer Res. 1987 Aug 1;47(15):4116-24. Cancer Res. 1987. PMID: 2440558
-
Malignant transformation of human fibroblasts by oncogene transfection or carcinogen treatment.Prog Clin Biol Res. 1990;340D:195-205. Prog Clin Biol Res. 1990. PMID: 2196579 Review.
-
Interactions between initiating chemical carcinogens, tumor promoters, and adenovirus in cell transformation.Teratog Carcinog Mutagen. 1980;1(3):245-57. doi: 10.1002/tcm.1770010302. Teratog Carcinog Mutagen. 1980. PMID: 6119815 Review.
Cited by
-
Effects of retinoic acid on NIH3T3 cell transformation by the H-ras oncogene.J Cancer Res Clin Oncol. 1991;117(2):102-8. doi: 10.1007/BF01613132. J Cancer Res Clin Oncol. 1991. PMID: 1706723 Free PMC article.
-
Characterization of the gag/fusion protein encoded by the defective Duplan retrovirus inducing murine acquired immunodeficiency syndrome.J Virol. 1990 Dec;64(12):5764-72. doi: 10.1128/JVI.64.12.5764-5772.1990. J Virol. 1990. PMID: 2243376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials